Enhance Lifesciences

Enhance Lifesciences is a venture studio dedicated to the creation and development of biotechnology companies focused on longevity and age-related diseases. Based in New York, the company identifies high-potential academic research in geroscience and translates it into therapeutic programs through a structured incubation process. Enhance provides its portfolio companies with seed capital, strategic guidance, and operational support, aiming to accelerate the path from discovery to clinical application. Its portfolio includes innovative startups such as Aeovian Pharmaceuticals, Deciduous Therapeutics, and Samsara Therapeutics, which target fundamental drivers of aging like mTOR signaling and cellular senescence. The company's mission is to extend human healthspan by developing a diverse pipeline of therapies for chronic and age-related conditions.